ATE480248T1 - Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung - Google Patents

Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung

Info

Publication number
ATE480248T1
ATE480248T1 AT05752662T AT05752662T ATE480248T1 AT E480248 T1 ATE480248 T1 AT E480248T1 AT 05752662 T AT05752662 T AT 05752662T AT 05752662 T AT05752662 T AT 05752662T AT E480248 T1 ATE480248 T1 AT E480248T1
Authority
AT
Austria
Prior art keywords
lactic acid
acid bacteria
gum bleeding
reduce gum
bleeding
Prior art date
Application number
AT05752662T
Other languages
English (en)
Inventor
Eamonn Connolly
Bo Moellstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Application granted granted Critical
Publication of ATE480248T1 publication Critical patent/ATE480248T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
AT05752662T 2004-06-14 2005-06-14 Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung ATE480248T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58027904P 2004-06-14 2004-06-14
US11/147,880 US20050281756A1 (en) 2004-06-14 2005-06-08 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
PCT/SE2005/000897 WO2005120527A1 (en) 2004-06-14 2005-06-14 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation

Publications (1)

Publication Number Publication Date
ATE480248T1 true ATE480248T1 (de) 2010-09-15

Family

ID=35480800

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05752662T ATE480248T1 (de) 2004-06-14 2005-06-14 Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung
AT10168703T ATE537837T1 (de) 2004-06-14 2005-06-14 Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT10168703T ATE537837T1 (de) 2004-06-14 2005-06-14 Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung

Country Status (19)

Country Link
US (2) US20050281756A1 (de)
EP (2) EP1765282B1 (de)
JP (1) JP2008502714A (de)
KR (1) KR20070018985A (de)
CN (2) CN1980683B (de)
AT (2) ATE480248T1 (de)
AU (2) AU2005251673C1 (de)
CA (1) CA2567867C (de)
DE (1) DE602005023463D1 (de)
DK (2) DK2229949T3 (de)
ES (1) ES2351153T3 (de)
IN (1) IN2006DE07651A (de)
NZ (1) NZ551860A (de)
PL (1) PL1765282T3 (de)
PT (1) PT1765282E (de)
SG (1) SG127405A1 (de)
SI (2) SI1765282T1 (de)
WO (1) WO2005120527A1 (de)
ZA (1) ZA200700211B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2448720C2 (ru) * 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
CN102115721B (zh) * 2008-05-08 2012-09-26 景岳生物科技股份有限公司 具有抗炎活性的乳杆菌分离株及其用途
DK2437758T3 (da) * 2009-06-03 2014-07-21 Chr Hansen As Bakterie thyA(-) mutanter med forøget vitamin K
US20110014324A1 (en) * 2009-07-10 2011-01-20 Christoffer Lundqvist Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution
WO2011007584A1 (ja) 2009-07-16 2011-01-20 国立大学法人広島大学 口腔内疾患の予防、改善又は治療剤
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
DE102011116325B4 (de) * 2011-10-14 2016-03-10 orochemie GmbH + Co. KG Neue Milchsäurebakterien und diese enthaltende Zusammensetzungen
EP3712168A3 (de) * 2011-12-28 2020-10-14 Amgen Inc. Verfahren zur behandlung von alveolarknochenverlust durch verwendung von anti-sclerostin-antikörpern
RU2492851C1 (ru) * 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
NZ744342A (en) * 2016-01-19 2022-11-25 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity
US20170273334A1 (en) * 2016-03-25 2017-09-28 Zoe Kapp Method of Naturally Decomposing Chewing Gum
EP3351259A1 (de) 2017-01-18 2018-07-25 Symrise AG Probiotika zur aggregation mit krankheitsassoziierten spezies in der mundhöhle
US12246078B2 (en) 2017-09-14 2025-03-11 Gerald P. Curatola Oral care formulations and methods for use
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
KR102720199B1 (ko) 2022-06-30 2024-10-22 대한제당 주식회사 우수한 프로폴리스 내성을 가진 신규 구강 유산균 락토바실러스 루테리 tsb-r7
CN118217218A (zh) * 2024-04-01 2024-06-21 天津大学 预防和治疗牙周炎的益生菌牙膏及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514469A (en) * 1974-08-01 1978-06-14 Beecham Group Ltd Oral hygiene compositions
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
ES2199305T3 (es) * 1995-12-21 2004-02-16 Biogaia Ab Uso de lactobacillus reuteri para inhibir criptosporidiosis en mamiferos.
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) * 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
KR19990024297A (ko) * 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US20030077814A1 (en) * 1997-08-07 2003-04-24 Oh Jong Suk Novel lactic acid bacteria
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
SI1312667T1 (sl) * 2000-08-25 2009-04-30 Wakamoto Pharma Co Ltd Probiotiäśni produkti, ki vsebujejo sev l. salivarius
KR100843020B1 (ko) * 2002-03-29 2008-07-01 가부시키가이샤 프렌테 인터내셔날 유산균을 유효성분으로 하는 생균제제 및 유산균 함유 식품
JP2003299480A (ja) * 2002-04-09 2003-10-21 Hiroki Futagawa 虫歯予防用細菌、虫歯予防用食品、虫歯予防用口腔洗浄剤及びヨーグルトの製造方法
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
CN1216145C (zh) * 2002-11-07 2005-08-24 上海新立工业微生物科技有限公司 一种嗜热乳酸杆菌以及采用该菌种生产l－乳酸的方法
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries

Also Published As

Publication number Publication date
CA2567867A1 (en) 2005-12-22
AU2005251673A1 (en) 2005-12-22
EP2229949B1 (de) 2011-12-21
ATE537837T1 (de) 2012-01-15
AU2005251673B2 (en) 2010-03-04
ZA200700211B (en) 2008-04-30
SI1765282T1 (sl) 2010-12-31
US20050281756A1 (en) 2005-12-22
KR20070018985A (ko) 2007-02-14
DK2229949T3 (da) 2012-02-06
ES2351153T3 (es) 2011-02-01
HK1101356A1 (en) 2007-10-18
EP1765282A1 (de) 2007-03-28
PT1765282E (pt) 2010-12-16
AU2010201837A1 (en) 2010-05-27
WO2005120527A1 (en) 2005-12-22
EP2229949A1 (de) 2010-09-22
DE602005023463D1 (de) 2010-10-21
JP2008502714A (ja) 2008-01-31
HK1180372A1 (zh) 2013-10-18
SG127405A1 (en) 2006-12-29
NZ551860A (en) 2009-12-24
EP1765282B1 (de) 2010-09-08
CA2567867C (en) 2012-04-10
IN2006DE07651A (de) 2007-08-17
SI2229949T1 (sl) 2012-04-30
CN1980683A (zh) 2007-06-13
PL1765282T3 (pl) 2011-03-31
DK1765282T3 (da) 2011-01-03
CN1980683B (zh) 2012-10-24
US20090238774A1 (en) 2009-09-24
CN102851350A (zh) 2013-01-02
CN102851350B (zh) 2015-12-16
AU2005251673C1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
ATE480248T1 (de) Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung
WO2009144458A3 (en) Food product
ATE369140T1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
DE60216614D1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
NO20076687L (no) Oral doseringsform
ATE408022T1 (de) Ermittlung des patientenbezogenen kariesrisikos
ATE344262T1 (de) 2-heteroarylcarbonsäureamide
ATE402924T1 (de) Pyridiniumsalze und deren verwendung
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
MY162652A (en) Novel use of quinolone antibiotics
ATE510818T1 (de) Kohlensäure- und schwefelsäuresalze von 3-(2,2,2- trimethylhydrazinium)propionatestern und deren verwendung zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat
IL194353A0 (en) Lysobactin amides
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
CO6620017A2 (es) Método y producto para el control del olor bucal
DE602005019703D1 (de) Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin
DE502005008925D1 (de) Substituierte nonadepsipeptide
WO2009059054A3 (en) Bacteria strains an d bacteriocin produced therefrom
DE502005007472D1 (de) Desoxo-nonadepsipeptide
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide
MY150686A (en) Oral composition containing morin
ATE361085T1 (de) Verwendung einer zusätzlich fermentierten getreideschlempe zur vorbeugung und/oder behandlung erhähter blutzucker-werte
DE602006016724D1 (de) Methode zur herstellung von gluten-freien kulturen der gattung penicillium und deren verwendung in blauschimmelmilchprodukten
WO2008121006A8 (en) Selenium administration
ATE427111T1 (de) Vorbeugung von zahnerosion durch die verwendung von colostrumprotein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1765282

Country of ref document: EP